Ads

 

Ads

 

Ads

 

Neurocrine Biosciences

Neurocrine Biosciences

World Rank (Aug-2026)
1534
Market Cap (Aug-2026)
15.524 Billion USD
World Rank (Jan-05-2024)
1,326
Market Cap (Jan-05-2024)
13.124 Billion USD
World Rank (Jul-30-2023)
1,672
Market Cap (Jul-30-2023)
10.026 Billion USD
World Rank (Jan-07-2022)
2,475
Market Cap (Jan-07-2022)
7.145 Billion USD
World Rank (Jan-01-2021)
1,837
Market Cap (Jan-01-2021)
8.955 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 628
Headquarters Country
Nasdaq / NYSE Code
NBIX
Employee Count
1,200
Employee Count as of Date
As on 2022
Headquarters City/State
World Region
World Subregion
Annual Revenue in USD
2,861 Million USD
Annual Operating Income in USD
619 Million USD
Annual Net Income in USD
479 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
4,632 Million USD
Total Liabilities in USD
1,378 Million USD
Total Equity in USD
3,253 Million USD
Balance Sheet for Period Ending
As of December-2025

Share

Ads